Three Biomarkers Predict Gastric Cancer Patients' Susceptibility To Fluorouracil-based Chemotherapy
Open Access
- 1 January 2019
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 10 (13) , 2953-2960
Abstract
Background: Fluorouracil-based chemotherapy is recommended by the main clinical guidelines for post-operative gastric cancer (GC) patient's chemotherapy treatment, this study aim to establish relate model to predict patients' susceptibility to fluorouracil-based chemotherapy to prevent patients' unnecessary exposure to chemotherapy treatments and improve patients' treatment.Keywords
This publication has 19 references indexed in Scilit:
- Gastric cancerThe Lancet, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal JunctionJournal of Clinical Gastroenterology, 2015
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesNature Medicine, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small MoleculesCell, 2013
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Benefit of Adjuvant Chemotherapy for Resectable Gastric CancerJAMA, 2010
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Strategies for discovering novel cancer biomarkers through utilization of emerging technologiesNature Clinical Practice Oncology, 2008